A Pre-Approval Information Exchange (PIE) Webinar sponsored by Sanofi.

During this webinar, the burden of disease in patients with hemophilia A and B, with or without inhibitors, the role of thrombin in hemostasis, and the efficacy and safety results from the ATLAS clinical development program will be discussed. An overview of the mechanism of action of the antithrombin lowering agent will also be presented. There will be a live Q&A to allow for interactive discussion.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP Member-only Webinar.

The AMCP Research Institute launched the RWE Initiative in 2024 to develop RWE standards that will facilitate efficient communication and ensure that RWE meets expectations and needs of formulary decision-makers. In this webinar, three speakers will engage in an interactive panel to discuss the importances and relevance of RWE, to describe the multi-stakeholder process for developing the standards through expert consensus, insights on how to apply the standards, and describe ongoing efforts to build a training program to support adoption of RWE in managed care.

An AMCP Market Insights Webinar.

Despite advancements in treatment, significant gaps remain in access, affordability, and comprehensive care for multiple sclerosis (MS). This session will feature a clinical key opinion leader and payer participants from the roundtable convened by AMCP in December 2024. Presenters will examine unmet patient needs in MS, the disease’s underlying pathogenesis, advancements in treatment, and payer perspectives on therapeutic value and evolving diagnostic approaches.

A Pre-Approval Information Exchange (PIE) Webinar sponsored by Abeona Therapeutics.

Prademagene Zamikeracel (pz-cel) Pre-Approval Information Exchange and Clinical Trial Data.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

The webinar will highlight the potential challenges in cGVHD management and review of the pivotal study data, follow up data and product profile of REZUROCK.

A Science & Innovation Webinar, sponsored by Abbvie.

The standard of care and refinement of treatment objectives continue to be enhanced by advancements in atopic dermatitis (AD) treatment. The benefits of achieving high treatment targets are now strong enough for medical guidelines to advocate for appropriate use of advanced therapies for AD. In budget constrained environments, payers need to understand how innovations are driving demand for novel mechanisms of action.

An AMCP Market Insights Webinar 

Join us for an engaging webinar exploring key considerations in the management and diagnosis of idiopathic hypersomnia (IH). The presenters will delve into the challenges of distinguishing IH from other sleep disorders, highlight advancements in diagnostic tools, and discuss evolving treatment strategies. Attendees will gain valuable insights into the broader impacts of IH on health outcomes and healthcare systems, with perspectives from clinical and payer experts.